Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

What should the investigator or sponsor submit to the IRB/IEC regarding trial status?

Ongoing communication with the IRB/IEC about how the trial is progressing is required. The investigator or sponsor should provide documented summaries of the trial status to the IRB/IEC in line with local regulatory requirements or whenever the IRB/IEC requests them. These summaries give a concise, written view of how recruitment and follow-up are going, any protocol amendments, deviations, safety signals, and overall progress, so the IRB can fulfill its continuing review and risk–benefit assessment. A investigator's CV is not a status update; it's about qualifications and eligibility, not the day-to-day progress of the trial. Monthly progress reports may be required in some settings, but they aren’t universally mandated as the standard mechanism for keeping the IRB informed. A final report only would miss the need for ongoing oversight and timely updates during the study.

Ongoing communication with the IRB/IEC about how the trial is progressing is required. The investigator or sponsor should provide documented summaries of the trial status to the IRB/IEC in line with local regulatory requirements or whenever the IRB/IEC requests them. These summaries give a concise, written view of how recruitment and follow-up are going, any protocol amendments, deviations, safety signals, and overall progress, so the IRB can fulfill its continuing review and risk–benefit assessment.

A investigator's CV is not a status update; it's about qualifications and eligibility, not the day-to-day progress of the trial. Monthly progress reports may be required in some settings, but they aren’t universally mandated as the standard mechanism for keeping the IRB informed. A final report only would miss the need for ongoing oversight and timely updates during the study.